This is one reason GLP-1 medications were first developed for type 2 diabetes and only later studied and approved for weight management
Gastrointestinal Issues : Since Semaglutide can cause nausea, vomiting, diarrhea, and other stomach issues, it may worsen symptoms in people with existing gastrointestinal conditions, such as irritable bowel syndrome (IBS) or gastroparesis (delayed stomach emptying)
Our clinicians prefer to classify these medications as incretin mimetics, which include drugs that act as GLP-1s, GLP-1/GIPs, and others
[PMID: 15032839] PubMed record related to this compound for laboratory literature review
This pulsatile release pattern is one reason ipamorelin tends to produce fewer side effects than direct HGH supplementation
Regenerador de otros antioxidantes: como la vitamina C y E